PDT Partners’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-28,779
| Closed | -$179K | – | 615 |
|
|
2022
Q4 | $179K | Sell |
28,779
-18,359
| -39% | -$114K | 0.03% | 550 |
|
|
2022
Q3 | $316K | Sell |
47,138
-90,735
| -66% | -$608K | 0.05% | 568 |
|
|
2022
Q2 | $877K | Sell |
137,873
-36,442
| -21% | -$232K | 0.08% | 436 |
|
|
2022
Q1 | $809K | Sell |
174,315
-66,520
| -28% | -$309K | 0.07% | 439 |
|
|
2021
Q4 | $1.2M | Buy |
240,835
+120,007
| +99% | +$600K | 0.09% | 323 |
|
|
2021
Q3 | $1.46M | Buy |
120,828
+16,428
| +16% | +$198K | 0.1% | 293 |
|
|
2021
Q2 | $2.21M | Buy |
104,400
+87,622
| +522% | +$1.85M | 0.15% | 259 |
|
|
2021
Q1 | $471K | Buy |
+16,778
| New | +$471K | 0.03% | 524 |
|
|
2020
Q3 | – | Sell |
-92,200
| Closed | -$4.73M | – | 761 |
|
|
2020
Q2 | $4.73M | Sell |
92,200
-11,367
| -11% | -$583K | 0.32% | 123 |
|
|
2020
Q1 | $3.27M | Buy |
103,567
+34,167
| +49% | +$1.08M | 0.26% | 119 |
|
|
2019
Q4 | $4.14M | Buy |
69,400
+5,094
| +8% | +$304K | 0.26% | 120 |
|
|
2019
Q3 | $2.36M | Sell |
64,306
-33
| -0.1% | -$1.21K | 0.14% | 183 |
|
|
2019
Q2 | $2.99M | Buy |
+64,339
| New | +$2.99M | 0.18% | 148 |
|
|
2017
Q2 | – | Sell |
-315,100
| Closed | -$11.1M | – | 532 |
|
|
2017
Q1 | $11.1M | Buy |
315,100
+270,200
| +602% | +$9.54M | 0.58% | 29 |
|
|
2016
Q4 | $562K | Sell |
44,900
-900
| -2% | -$11.3K | 0.04% | 385 |
|
|
2016
Q3 | $634K | Buy |
+45,800
| New | +$634K | 0.04% | 351 |
|